AccueilPRQR • NASDAQ
add
ProQR Therapeutics NV
Dernière clôture
1,64 $
Variation sur la journée
1,64 $ - 1,75 $
Plage sur l'année
1,08 $ - 3,10 $
Capitalisation boursière
182,30 M USD
Volume moyen
603,08 k
Ratio cours/bénéfices
-
Rendement (dividendes)
-
Place boursière principale
NASDAQ
Actualités des marchés
À propos
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia
Date de fondation
2012
Site Web
Employés
166